Stay updated on Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial

Sign up to get notified when there's something new on the Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed older notices (including the government funding lapse alert and Revision: v3.4.1). These are maintenance-related changes and do not affect the study details.
    Difference
    0.4%
    Check dated 2026-02-11T14:11:53.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A government funding notice was added to the page and the revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:16:30.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Glossary link added; capitalization of QC-related labels standardized; page revision updated to v3.4.0 from v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T05:13:34.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.4 and no longer shows v3.3.3, reflecting a minor revision update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:14:25.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    A centralized Locations section now lists District of Columbia, Florida, New Jersey, and New York as study sites, replacing separate location subsections and removing the HHS Vulnerability Disclosure link.
    Difference
    0.5%
    Check dated 2025-12-23T21:15:18.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2; no study content or eligibility details were affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:59:49.000Z thumbnail image

Stay in the know with updates to Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial page.